SOTERA HEALTH COMPANY Payments to Acquire Productive Assets
SOTERA HEALTH COMPANY (SHC) reported Payments to Acquire Productive Assets of $214.97 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2024-02-27
- SOTERA HEALTH COMPANY payments to acquire productive assets for the quarter ending 2023-12-31 was $64.83M, a 9.63% decline year-over-year.
- SOTERA HEALTH COMPANY payments to acquire productive assets for the quarter ending 2022-12-31 was $71.74M, a 73.85% increase year-over-year.
- SOTERA HEALTH COMPANY payments to acquire productive assets for the quarter ending 2022-09-30 was $39.00M, a 142.10% increase year-over-year.
- SOTERA HEALTH COMPANY payments to acquire productive assets for the quarter ending 2021-12-31 was $41.26M, a 107.70% increase year-over-year.
- SOTERA HEALTH COMPANY payments to acquire productive assets for fiscal 2023 was $214.97M, a 17.87% increase from fiscal 2022.
- SOTERA HEALTH COMPANY payments to acquire productive assets for fiscal 2022 was $182.38M, a 78.52% increase from fiscal 2021.
- SOTERA HEALTH COMPANY payments to acquire productive assets for fiscal 2021 was $102.16M, a 90.93% increase from fiscal 2020.
- SOTERA HEALTH COMPANY payments to acquire productive assets for fiscal 2020 was $53.51M, a 6.55% decline from fiscal 2019.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $64.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $214.97M 10-K · filed 2024-02-27 | ||
| 2023-09-30 | $150.15M 10-Q · filed 2023-11-01 | |||
| 2022-12-31 | $71.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $110.74M derived: sum of 2 quarters · filed 2024-02-27 | $182.38M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $110.64M 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $71.64M 10-Q · filed 2022-08-04 | |||
| 2021-12-31 | $41.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $57.37M derived: sum of 2 quarters · filed 2024-02-27 | $102.16M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $16.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $60.90M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $44.79M 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $19.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $30.07M derived: sum of 2 quarters · filed 2023-02-28 | $53.51M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $33.64M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $23.44M 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $57.26M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |